Fibrodysplasia ossificans progressiva diagnosed as ankylosing spondylitis: A case report

Introduction: Fibrodysplasia (myositis) ossificans progressiva is a rare and very crippling form of disease characterized by great toe malformation and heterotopic bone formation. We herein report a case of fibrodysplasia ossificans progressiva in whom the onset of complaints was after 20 years of age which led physicians to confuse this case with ankylosing spondylitis. Case Report: A 35-year-old male was referred to us by a physician for operative management of multiple joint deformities secondary to ankylosing spondylitis. However, the history and radiological findings were not consistent with ankylosing spondylitis. Clinical finding of symmetrical valgus malformations of great toes and radiological findings of heterotopic ossifications at multiple sites clinched the diagnosis of fibrodysplasia ossificans progressiva. Plans of surgery were declined after discussion with patient. Conclusion: Fibrodysplasia ossificans progressiva is an exceedingly uncommon genetic disorder. Erroneous diagnoses are very frequent and are commonly associated with apparent iatrogenic harm because of invasive diagnostic or potentially harmful therapeutic interventions. The correct diagnosis of fibrodysplasia ossificans progressiva can be made clinically even before radiographic evidence of heterotopic ossification is seen. (This page in not part of the published article.) IJCRI – International Journal of Case Reports and Images, Vol. 5 No. 1, January 2014. ISSN – [0976-3198] IJCRI 2014;5(1):62–65. www.ijcasereportsandimages.com Thete et al. 62 CASE REPORT OPEN ACCESS Fibrodysplasia ossificans progressiva diagnosed as ankylosing spondylitis: A case report Sandesh S Thete, Eknath D Pawar, Gaurav Bafna, Purushottam Pawar

is a rare and very crippling form of disease characterized by great toe malformation and heterotopic bone formation. We herein report a case of fibrodysplasia ossificans progressiva in whom the onset of complaints was after 20 years of age which led physicians to confuse this case with ankylosing spondylitis. case report: A 35-yearold male was referred to us by a physician for operative management of multiple joint deformities secondary to ankylosing spondylitis. However, the history and radiological findings were not consistent with ankylosing spondylitis. clinical finding of symmetrical valgus malformations of great toes and radiological findings of heterotopic ossifications at multiple sites clinched the diagnosis of fibrodysplasia ossificans progressiva. Plans of surgery were declined after discussion with patient. conclusion: Fibrodysplasia ossificans progressiva is an exceedingly uncommon genetic disorder. Erroneous diagnoses are very frequent and are commonly associated with apparent iatrogenic harm because of invasive diagnostic or potentially harmful therapeutic interventions. the correct diagnosis of fibrodysplasia ossificans progressiva can be made clinically even before radiographic evidence of heterotopic ossification is seen.

IntrOductIOn
Fibrodysplasia (myositis) ossificans progressiva (FOP) is a rare and very crippling form of disease characterized by great toe malformation and heterotopic bone formation [1,2]. It has an incidence of one in two million. Usual age of onset of symptoms and presentation is within first decade [1,2]. We herein report a case of FOP in whom the onset of complaints was after 20 years of age. This wrongly led physicians to confuse this case with ankylosing spondylitis. We review the main clinical features, medical treatments and role of surgical management in FOP. www.ijcasereportsandimages.com Thete et al. 63

cAsE rEPOrt
A 35-year-old male was referred to us by a physician for operative management of multiple joint deformities secondary to ankylosing spondylitis. When he first visited the outpatient department of our institute for consultation, one of the authors also made the same diagnosis. His history was suggestive of ankylosing spondylitis as he had gradual onset of pain and slowly progressive morning stiffness in his twenties. He had exaggerations and remissions over years till the disease progressed to its present status. But he never had the classic complain of morning stiffness seen in ankylosing spondylitis. Moreover both his daughters, aged 15 years and 11 years, were having similar complaints which did not fit into picture of ankylosing spondylitis.
On examination he walked with the help of crutches with stooped posture. Lumbar lordosis was obliterated with generalized straightening of spinal curvatures but no obvious kyphosis was noted ( Figure 1). A hard swelling was palpable in left adductor group of muscle and several small swellings were palpable in para spinal muscles and around elbow and ankle. No movements were possible in spine while both hips and elbow were fused in flexion. Shoulder and knee joint had preserved functional range of motion. These examination findings and history were not classical of ankylosing spondylitis yet it could not be ruled out. However, the patient had bilateral malformation of both big toes which he said that were present since birth and they were hypoplastic, valgoid and stiff (Figures 2, 3). Then the diagnosis of FOP was considered in this patient.
On radiological examination with radiographs of lumbar and cervical spine, heterotopic bone formation was noted in paraspinal muscles ( Figure 4A). Disc spaces were normal and no marginal syndesmophytes were noted ( Figure 4B). A more pronounced heterotopic mass was seen in left adductor group of muscle. Trabeculations were noted in heterotopic bone suggesting it was mature lamellar bone. Laboratory investigations of the patient were negative for HLA B27 and rest of biochemical markers were within normal limits. Supported with this clinical and investigational data, diagnosis of FOP was made. The patient declined the surgical intervention.  dIscussIOn Fibrodysplasia ossificans progressiva is an exceedingly uncommon genetic disorder characterized by congenital bilateral malformation of big toe and progressive heterotopic ossification in mesodermal tissues such as muscles, aponeurosis, fascia, tendon and ligaments [3]. Affected individuals are normal at birth except for great toe malformations and average age of presentation is in first decade (range 1-25 years) [2]. Kitterman et al. reported 90% of these patients received some wrong or hazardous treatment before proper diagnosis [4]. Misdiagnoses of cancer or fibromatosis, including aggressive juvenile fibromatosis and desmoid tumor, were given to 37% patients. Other misdiagnoses given, in order of frequency, are injuries attributable to trauma or overuse, myositis, rheumatoid arthritis, ankylosing spondylitis, neurofibromatosis and scleroderma [8]. Involvement usually progresses from axial to appendicular and cranial to caudal [3]. They usually present in flare ups following triggering events like trauma, immunizations, influenza like infections or muscle fatigue. Painful swellings appear in skeletal muscles during flare ups which subside in size and become hard as mature bone is formed. Histopathological examination of painful swellings during flare up shows various stages of mature bone formation and mature bone during quiescence [5]. However, invasive investigations, like biopsy, can lead to flare ups and hence avoided. Biochemical markers of bone formation and inflammation are normal, except during flare ups when their values are very high [6]. Radiographs reveal heterotopic bone formation at various sites [3]. Diagnosis is made clinically based on the findings of congenital symmetrical malformation of big toe and progressiva heterotopic bone formation.
The genetic basis is traced to a recurrent heterozygous missense point mutation on chromosome 2q.23-24 region. It causes abnormality in ACVR1/ALK2 receptors in BMP signaling pathway [7]. This causes profound dysregulation of BMP signaling pathway, particularly over expression of BMP4, leading to uncontrolled heterotopic enchondral ossifications [5,8]. Both sporadic and familial case have been reported with 90% of cases are new mutations and 10% familial cases with autosomal dominant mode of transmission.
Average life expectancy of these individuals is 40 years with cause of death in most cases being thoracic insufficiency syndrome due to chest wall immobility [9]. To the date of writing this article no single effective treatment has been agreed upon and controversies continue. Generally, management needs a well-structured and individualized approach focusing on the following [10]: (i) early diagnosis (ii) avoidance of injury or iatrogenic harm (iii) symptomatic treatment during flare ups (iv) optimization of residual function Various drug classes can be used for management like steroids, NSAIDs, mast cell stabilizers, chemotherapy agents, radiotherapy, bone marrow transplantation are few to mention [10]. Definitive target for therapy is gene therapy with noggin, a BMP4 antagonist in BMP signaling pathway. Surgery is usually deferred in these individuals because risks, which start from anesthesia to flare ups away from operative site postoperatively, outweigh the benefits of any operative intervention. Hence adventurous interventions like surgery should be undertaken in clear indications and after thorough discussion with affected individuals and their relatives [4].
This case reinforces the importance of thorough history and clinical examination aiding in diagnosis, avoiding unnecessary investigations and potentially harmful interventions.
cOncLusIOn Fibrodysplasia ossificans progressiva (FOP) is an exceedingly uncommon genetic disorder. Erroneous diagnoses are very frequent and are commonly associated with apparent iatrogenic harm to individuals affected with FOP. The correct diagnosis of fibrodysplasia ossificans progressiva can be made clinically even before radiographic evidence of heterotopic ossification is seen. Errors in diagnosis can lead to invasive diagnostic procedures (surgical or needle biopsies) or unnecessary therapeutic interventions (surgery, chemotherapy, or physical therapy) which can result in permanent disability, which can be avoided with correct diagnosis.

Edorium Journals: An introduction
Edorium Journals Team

But why should you publish with Edorium Journals?
In less than 10 words -we give you what no one does.

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial Review
All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review.

Peer Review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early View version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your email.

Mentored Review Articles (MRA)
Our academic program "Mentored Review Article" (MRA) gives you a unique opportunity to publish papers under mentorship of international faculty. These articles are published free of charges.

Most Favored Author program
Join this program and publish any number of articles free of charge for one to five years.

Favored Author program
One email is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing.

Institutional Membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all.

Our presence
We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle. Something more...
We request you to have a look at our website to know more about us and our services.
We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge.

Four weeks
After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript.